Is the biopharmaceutical supply chain fit for purpose given the growth of our industry? How far have we come in raw material supply management, and what still needs to be accomplished to ensure the delivery of safe and effective drugs?
Explore this overview of the resin manufacturing process and how a reliable product discontinuation policy, commitment to business continuity management, and capacity expansion plans can help alleviate supply chain issues.
Get insights into implementing a robust business continuity management program that can help secure supply, reduce risks, and maintain quality in manufacturing operations, from daily production through a crisis situation.
Explore Cytiva’s brand new single-use production facility in Wales, UK. This facility forms part of Cytiva and Pall Corporation’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.
Learn more about Cytiva’s Security of Supply program
Visit Cytiva's Security of Supply web page for information on supply chain topics, including the company’s product discontinuation policy, how to subscribe to the change control notification process, strategic reserves and business continuity management, production facility expansions, and more.
E-learning on Security of Supply
This free online course provides a foundation for understanding how to secure the biopharma supply chain. Learn more.